„QALY“
Suchergebnisse
1.000+ Treffer
-
Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies
-
Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland–Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data
-
Exploring a new method for deriving the monetary value of a QALY
-
Aktuelle Therapie der Patientin mit einem Mammakarzinom
-
Estimating a constant WTP for a QALY—a mission impossible?
-
NICE collaborating on 'Extending the QALY' project
-
Zuteilungskriterien im Gesundheitswesen: Grenzen und Alternativen – Eine Einführung mit medizinethischen und philosophischen Verortungen
-
Are some QALYs more equal than others?
-
Estimating QALYs in adults with cerebral palsy: mapping the San Martin scale to the EQ-5D-5L for economic evaluation
-
Reduction of quality-adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD)
-
Health Services Research and Health Economy – Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology
-
Age-Differentiated QALY Losses
-
Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs”
-
QALY-time: experts’ view on the use of the quality-adjusted life year in cost-effectiveness analysis in palliative care
-
The integrated care pathway for managing post stroke patients (iCaPPS©) in public primary care Healthcentres in Malaysia: impact on quality adjusted life years (QALYs) and cost effectiveness analysis
-
Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
-
How Default Choice and Priority Rule Affects Organ Donation: An Examination of Hypotheses
-
QALYs versus HYEs - What's Right and What's Wrong
-
Ermittlung von Nutzwerten arbeitsmedizinisch relevanter Erkrankungen aus der Perspektive von betroffenen und nichtbetroffenen Versicherten
-
Langfristige Kosteneffektivität der Mammareduktionsplastik bei Patientinnen mit Makromastie aus Sicht der Kostenträger und der Gesellschaft